Disclosures for "First in Class ASO Targeting SNCA p.A53T Allele: Preclinical Efficacy"
-
Christina Tyner has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc. Christina Tyner has stock in Vanda Pharmaceuticals Inc..
-
Dr. Smieszek has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc.. Dr. Smieszek has stock in Vanda Pharmaceuticals Inc..
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Gunther Birznieks has received personal compensation for serving as an employee of Vanda Pharmaceuticals. Gunther Birznieks has received intellectual property interests from a discovery or technology relating to health care.
-
Author has nothing to disclose
-
Mihael Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals . Mihael Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals . Mihael Polymeropoulos has stock in Vanda Pharmaceuticals .